OTCMKTS:BAYRY

Bayer Aktiengesellschaft - BAYRY Stock Forecast, Price & News

$11.56

-0.16 (-1.37%)

(As of 09/30/2022 09:02 PM ET)

Add

Compare

Today's Range: $11.48
▼
$11.71
50-Day Range: $11.56
▼
$15.00
52-Week Range: $11.41
▼
$18.45

Volume: 873,700 shs
Average Volume: 656,496 shs
Market Capitalization: $45.43 billion

P/E Ratio: 9.40
Dividend Yield: 3.03%
Price Target: $85.00

Bayer Aktiengesellschaft MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.91 Rating Score
Upside/Downside: 635.3% Upside
$85.00 Price Target
Short Interest: Healthy
0.01% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.23
Based on 9 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 5.42%
From $2.03 to $2.14 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.58 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Bayer Aktiengesellschaft has received a consensus rating of Buy. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $85.00, Bayer Aktiengesellschaft has a forecasted upside of 635.3% from its current price of $11.56.
Amount of Analyst Coverage
Bayer Aktiengesellschaft has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.01% of the outstanding shares of Bayer Aktiengesellschaft have been sold short.
Short Interest Ratio / Days to Cover
Bayer Aktiengesellschaft has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Bayer Aktiengesellschaft has recently increased by 190.69%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Yield
Bayer Aktiengesellschaft pays a meaningful dividend of 3.00%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Bayer Aktiengesellschaft does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Bayer Aktiengesellschaft is 28.46%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 16.36% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for BAYRY.

2.4

News and Social Media Coverage

News Sentiment
Bayer Aktiengesellschaft has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 9 news articles for Bayer Aktiengesellschaft this week, compared to 5 articles on an average week.
Search Interest
4 people have searched for BAYRY on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
MarketBeat Follows
Only 2 people have added Bayer Aktiengesellschaft to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bayer Aktiengesellschaft insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.02% of the stock of Bayer Aktiengesellschaft is held by institutions.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Bayer Aktiengesellschaft are expected to grow by 5.42% in the coming year, from $2.03 to $2.14 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bayer Aktiengesellschaft is 9.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.75.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bayer Aktiengesellschaft is 9.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 122.95.
Price to Earnings Growth Ratio
Bayer Aktiengesellschaft has a PEG Ratio of 1.00. PEG Ratios around 1 indicate that a company is correctly valued.
Price to Book Value per Share Ratio
Bayer Aktiengesellschaft has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

October 2, 2022 | bbc.com

Bayern Munich 4-0 Bayer Leverkusen: Sadio Mane, Leroy Sane and Thomas Muller star as Bayern cruise to victory

September 30, 2022 | msn.com

Superb Jamal Musiala guides Bayern Munich to 'brutal' win over Bayer Leverkusen

September 30, 2022 | msn.com

Bayern München vs Bayer Leverkusen LIVE: Bundesliga result, final score and reaction

September 30, 2022 | msn.com

Bayern Munich v Bayer Leverkusen: Where To Watch, Live Stream, UK, US, Canada, India, Australia

September 29, 2022 | msn.com

Bayern Munich vs Bayer Leverkusen: Live stream, TV channel, kick-off time & where to watch

September 29, 2022 | msn.com

Hudson-Odoi quizzed on Chelsea recall option after summer loan transfer to Bayer Leverkusen

September 29, 2022 | msn.com

Bayern Munich seeking struggling Sadio Mane turnaround against Bayer Leverkusen

September 27, 2022 | msn.com

Bayer launches novel treatment to reduce cardiovascular deaths in India

September 26, 2022 | benzinga.com

Bayer Announces Further Investment in Direct Relief Community Health Awards Program

September 23, 2022 | bbc.com

Gossip: Hudson-Odoi attracting attention at Bayer Leverkusen

September 22, 2022 | businessinsider.com

Embattled CEO Werner Baumann enters his final chapter at Bayer, aiming to turn the German pharma giant into a cancer powerhouse

September 20, 2022 | finance.yahoo.com

EXPLAINER-Biotech corn and soy widely used, consumers still wary of GM wheat

September 20, 2022 | finance.yahoo.com

Food Supply Stays Tight as Disappointing U.S. Harvest Adds to Global Challenges

September 17, 2022 | msn.com

' He Is Very Valuable To Us' - Bayer Leverkusen Manager Gerardo Seoane On Callum Hudson-Odoi

September 17, 2022 | msn.com

Bayer Leverkusen vs Werder Bremen LIVE: Bundesliga latest score, goals and updates from fixture

September 16, 2022 | msn.com

Report: Manchester City Are Interested In Bayer Leverkusen's Moussa Diaby

September 16, 2022 | bloomberg.com

Bayer's Embattled CEO Isn't Feeling Pressure to Change Strategy

September 15, 2022 | reuters.com

Bayer CEO says supply shortages cut crop protection sales in 2022

September 15, 2022 | markets.businessinsider.com

DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

September 15, 2022 | msn.com

Atletico Madrid slump to 0-2 defeat v Bayer

September 14, 2022 | bizjournals.com

Former Bayer exec takes over as CEO of St. Louis agtech startup

September 14, 2022 | msn.com

Bayer Leverkusen's late goals from Robert Andrich and Moussa Diaby sink Atletico Madrid in Champions League

September 13, 2022 | msn.com

Bayer Leverkusen vs. Atletico Madrid live stream, TV channel, time, lineups, how to watch

September 13, 2022 | msn.com

Green Bay School Board meeting ends abruptly after Superintendent Vicki Bayer has medical emergency

September 12, 2022 | msn.com

Bayer Leverkusen vs Atletico Madrid: Live stream, TV channel, kick-off time & where to watch

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Company Calendar

Last Earnings: 8/04/2022
Today: 10/02/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BAYRY
CUSIP: N/A
CIK: 1144145
Web: www.bayer.com
Phone: 49214301
Fax: 49-21-4306-6328
Employees: 99,637
Year Founded: 1863

Price Target and Rating

Average Stock Price Forecast: $85.00
High Stock Price Forecast: $96.00
Low Stock Price Forecast: $79.00
Forecasted Upside/Downside: +635.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.91
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.23
Trailing P/E Ratio: 9.40
Forward P/E Ratio: 5.69
P/E Growth: 1
Net Income: $1.18 billion
Net Margins: 8.84%
Pretax Margin: 10.33%
Return on Equity: 21.56%
Return on Assets: 6.14%

Debt

Debt-to-Equity Ratio: 1.00
Current Ratio: 1.18
Quick Ratio: 0.84

Sales & Book Value

Annual Sales: $52.16 billion
Price / Sales: 0.87
Cash Flow: $2.81 per share
Price / Cash Flow: 4.12
Book Value: $9.99 per share
Price / Book: 1.16

Miscellaneous

Outstanding Shares: 3,929,696,000
Free Float: N/A
Market Cap: $45.43 billion
Optionable: Not Optionable
Beta: 1.09

Social Links

Key Executives

Mr. Werner Baumann (Age 60)
Chairman of Management Board, CEO & Chief Sustainability Officer
Comp: $5.7M

Mr. Wolfgang U. Nickl (Age 53)
CFO & Member of Management Board
Comp: $2.25M

Mr. Heiko W. J. Schipper (Age 53)
Member of Management Board & Pres of the Consumer Health Division
Comp: $2.43M

Mr. Stefan Oelrich (Age 54)
Head of the Pharmaceuticals Division & Member of the Board of Management
Comp: $3.01M

Ms. Sarena S. Lin (Age 51)
Chief Transformation & Talent Officer, Labor Director and Member of Management Board
Comp: $3.17M

Mr. Rodrigo Santos (Age 49)
Member of Management Board & Pres of the Crop Science Division

Mr. Bernd-Peter Bier (Age 55)
Head of Accounting and Head of Taxes

Mr. Oliver Maier
Head of Investor Relations

Dr. Gabriel Harnier (Age 51)
Head of Law, Patents & Compliance

Mr. Michael Preuss
Head of Communications, Gov. Relations and Corp. Brand

Key Competitors

View All Competitors

BAYRY Stock - Frequently Asked Questions

Should I buy or sell Bayer Aktiengesellschaft stock right now?: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bayer Aktiengesellschaft in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BAYRY shares.
View BAYRY analyst ratings or view top-rated stocks.
What is Bayer Aktiengesellschaft's stock price forecast for 2022?: 11 Wall Street research analysts have issued twelve-month price objectives for Bayer Aktiengesellschaft's shares. Their BAYRY share price forecasts range from $79.00 to $96.00. On average, they predict the company's share price to reach $85.00 in the next year. This suggests a possible upside of 635.3% from the stock's current price.
View analysts price targets for BAYRY or view top-rated stocks among Wall Street analysts.
How have BAYRY shares performed in 2022?: Bayer Aktiengesellschaft's stock was trading at $13.26 at the start of the year. Since then, BAYRY shares have decreased by 12.8% and is now trading at $11.56.
View the best growth stocks for 2022 here.
Are investors shorting Bayer Aktiengesellschaft?: Bayer Aktiengesellschaft saw a increase in short interest in August. As of August 31st, there was short interest totaling 136,400 shares, an increase of 74.2% from the August 15th total of 78,300 shares. Based on an average daily volume of 1,274,700 shares, the days-to-cover ratio is currently 0.1 days.
View Bayer Aktiengesellschaft's Short Interest.
How were Bayer Aktiengesellschaft's earnings last quarter?: Bayer Aktiengesellschaft (OTCMKTS:BAYRY) announced its quarterly earnings results on Thursday, August, 4th. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.05. The business had revenue of $13.66 billion for the quarter, compared to the consensus estimate of $12.28 billion. Bayer Aktiengesellschaft had a net margin of 8.84% and a trailing twelve-month return on equity of 21.56%.
How often does Bayer Aktiengesellschaft pay dividends? What is the dividend yield for Bayer Aktiengesellschaft?: Bayer Aktiengesellschaft declared a dividend on Friday, April 29th. Stockholders of record on Tuesday, May 3rd will be paid a dividend of $0.3693 per share on Monday, May 16th. This represents a dividend yield of 2.26%. The ex-dividend date is Monday, May 2nd.
Read our dividend analysis for BAYRY.

Is Bayer Aktiengesellschaft a good dividend stock?: Bayer Aktiengesellschaft (OTCMKTS:BAYRY) pays an annual dividend of $0.35 per share and currently has a dividend yield of 3.03%. The dividend payout ratio is 28.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BAYRY will have a dividend payout ratio of 16.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BAYRY.
What guidance has Bayer Aktiengesellschaft issued on next quarter's earnings?: Bayer Aktiengesellschaft issued an update on its FY 2022 earnings guidance on Thursday, August, 25th. The company provided earnings per share guidance of $8.21-$8.21 for the period. The company issued revenue guidance of $53.29 billion-$54.35 billion, compared to the consensus revenue estimate of $50.85 billion.
What is Bayer Aktiengesellschaft's stock symbol?: Bayer Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "BAYRY."
How do I buy shares of Bayer Aktiengesellschaft?: Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bayer Aktiengesellschaft's stock price today?: One share of BAYRY stock can currently be purchased for approximately $11.56.
How much money does Bayer Aktiengesellschaft make?: Bayer Aktiengesellschaft (OTCMKTS:BAYRY) has a market capitalization of $45.43 billion and generates $52.16 billion in revenue each year. The company earns $1.18 billion in net income (profit) each year or $1.23 on an earnings per share basis.
How many employees does Bayer Aktiengesellschaft have?: The company employs 99,637 workers across the globe.
Does Bayer Aktiengesellschaft have any subsidiaries?: The following companies are subsidiares of Bayer Aktiengesellschaft: AB Seeds Ltd, AB Seeds Sales (2006) Ltd, AO Bayer, Adverio Pharma GmbH, AgrEvo Verwaltungsgesellschaft mbH, AgraQuest Inc., Alcafleu Management GmbH & Co. KG, Algeta, Artificial Muscle Inc, Asklepios BioPharmaceutical, Athenix Corp., Atlantic Breeders S. A. R. L., BUS C.V., Bayer (Proprietary) Limited, Bayer (Schweiz) AG, Bayer 04 Immobilien GmbH, Bayer 04 Leverkusen Fußball GmbH, Bayer A / S, Bayer AB, Bayer AS, Bayer Agriculture BVBA, Bayer Agriculture Limited, Bayer Algerie S. P. A., Bayer Altersversorgung GmbH, Bayer Animal Health GmbH, Bayer Austria Gesellschaft m.b.H., Bayer B.V., Bayer Beteiligungsverwaltung Goslar GmbH, Bayer Beteiligungsverwaltungsgesellschaft mbH & Co. OHG, Bayer Bitterfeld GmbH, Bayer Bulgaria EOOD, Bayer Business Services GmbH, Bayer Canadian Holdings Inc., Bayer Capital Corporation B.V., Bayer Chemicals GmbH, Bayer Consumer Care AG, Bayer Consumer Care Holdings LLC, Bayer Corporation, Bayer CropScience, Bayer CropScience (Portugal)-Produtos para a Agricultura Lda, Bayer CropScience Beteiligungsgesellschaft mit beschränkter Haftung, Bayer CropScience Biologics GmbH, Bayer CropScience Deutschland GmbH, Bayer CropScience Holding Inc., Bayer CropScience Holding SA, Bayer CropScience Holdings Inc., Bayer CropScience Inc., Bayer CropScience LLC, Bayer CropScience LP, Bayer CropScience Limited, Bayer CropScience NV, Bayer CropScience S. L., Bayer CropScience S. r. l., Bayer CropScience Schweiz AG, Bayer CropScience Vermögensverwaltungsgesellschaft mbH, Bayer East Coast LLC, Bayer Essure Inc., Bayer HealthCare Animal Health Inc., Bayer HealthCare Holdings LLC, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare US Funding II LLC, Bayer HealthCare US Funding LLC, Bayer Inc., Bayer International Trade Services Corporation, Bayer Medical Care Inc., Bayer New AU M1059 USD LLC, Bayer New AU M3650 LLC, Bayer New BE M3155 LLC, Bayer New CA M5015 LLC, Bayer New CH M3868 LLC, Bayer New CZ M3204 LLC, Bayer New DE M3385 LLC, Bayer New Gewas I M3640 LLC, Bayer New Gewas II M3640 LLC, Bayer New HU M3440 LLC, Bayer New MA M3130 LLC, Bayer New MX M3640 LLC, Bayer New MY M1455 LLC, Bayer New NL M3644 LLC, Bayer New Oogst M3648 LLC, Bayer New PL M3655 LLC, Bayer New RO M3695 LLC, Bayer New RU M3708 LLC, Bayer New TH M1763 LLC, Bayer New TK M3970 LLC, Bayer New UA M3702 LLC, Bayer New UK M3939 LLC, Bayer New Veggie M3617 M5157 LLC, Bayer New Veggie Mig M3617 M5157 LLC, Bayer New ZA M3743 LLC, Bayer Overseas Trade Services Corporation, Bayer Puerto Rico Inc., Bayer U.S. LLC, Bayer US Finance II LLC, Bayer US Finance LLC, Bayer US Holding LP, Bayer West Coast Corporation, Bayer World Investments B.V., Bayer d. o. o., Bayer spol. sr. o., Bayer-Handelsgesellschaft mit beschränkter Haftung, Beeologics Admin LLC, Beeologics Holdings Limited, Beeologics LLC, Beeologics USA Inc, Berlimed S. A., Berlipharm B.V., Berlis AG, Biogenetic Technologies B.V., BlueRock Therapeutics, Care/of, Channel Bio LLC, Chemion Logistik GmbH, Collateral Therapeutics Inc., Conceptus SAS La Garenne, Cooper Land Company of New Jersey Inc., Coppertone LLC, Corn States LLC, Dihon Pharmaceutical, Dr. Scholl’s LLC, Dritte Bayer Real Estate VV GmbH & Co. KG, Erste Bayer Real Estate VV GmbH & Co. KG, Erste K-W-A Beteiligungsgesellschaft mbH, EuroServices Bayer S. L., Fünfte Bayer Real Estate VV GmbH & Co., GP Grenzach Produktions GmbH, Grass Roots Biotechnology LLC, Hornbeck Seed Company Inc., Icon Genetics, Intendis GmbH, Intraserv GmbH & Co., Jenapharm GmbH & Co. KG, KVP Pharma+Veterinär Produkte GmbH, KWA Investment II LLC Research, KWA Investment III LLC, KWA Investment IV LLC, KaNDy Therapeutics, MENADIER Heilmittel GmbH, MNL Luxembourg S. a. r. l., MONSANTO Hungaria Kft., MONSANTO Saaten GmbH, Merck-Consumer Care (MCC), MiraLAX LLC, Monsanto ACUA MHC LLC, Monsanto AG Netherlands I C.V., Monsanto AG Netherlands II C.V., Monsanto AGN Holding LLC, Monsanto Ag B.V., Monsanto Agrar Deutschland GmbH, Monsanto Agricultura España S. L., Monsanto Agricultura Italia S.p.A., Monsanto Agriculture Nigeria Limited, Monsanto Burkina Faso SARL, Monsanto CR s. r. o., Monsanto Canada ULC, Monsanto Caribe LLC, Monsanto Company, Monsanto Crop B.V., Monsanto Crop Sciences Denmark A/S, Monsanto Crop Sciences Norway A/S, Monsanto Crop Sciences Sweden A.B., Monsanto Finance SA, Monsanto Gesellschaft m. b. H., Monsanto Gida Ve Tarim Ticaret Ltd, Monsanto Grain B.V., Monsanto Great Lakes Production Co LLC, Monsanto Hawaii Production Co LLC, Monsanto Hellas Agriculturals Ltd, Monsanto Holding I C.V., Monsanto Holding II C.V., Monsanto Holding III C.V., Monsanto Holding Ukraine Ltd, Monsanto Holland B.V., Monsanto II Lda, Monsanto Illinois Production Co LLC, Monsanto Inter-America Company, Monsanto International Sarl, Monsanto Invest B.V., Monsanto Iowa Production Co LLC, Monsanto Ireland Limited, Monsanto Jordan LLC, Monsanto Kenya Ltd, Monsanto Kool BV, Monsanto LA Holdings II Co LLC, Monsanto Latin America Holdings Co LLC, Monsanto MGCV MHC LLC, Monsanto MSCV Holding LLC, Monsanto MYCV MHC LLC, Monsanto Malawi Ltd, Monsanto Missouri Production Co LLC, Monsanto NL BV, Monsanto Northern Production Co LLC, Monsanto Oogst B.V., Monsanto Operations B.V., Monsanto Polska Sp. z o. o., Monsanto Production Supply LLC, Monsanto Romania SRL, Monsanto Rus LLC, Monsanto S.A.S., Monsanto Seed Supply LLC, Monsanto Seeds LLC, Monsanto Serbia D. O. O., Monsanto Slovakia S. R. O., Monsanto South Africa (PTY) Ltd, Monsanto Southern Production Co LLC, Monsanto Tanzania Limited, Monsanto Technology International LLC, Monsanto Technology LLC, Monsanto Treasury Services SARL, Monsanto UK Limited Cambridge U. K., Monsanto Vegetable Holding LLC, Monsanto Vegetable IP Holding C.V., Monsanto Vegetable IP Management BV, Monsanto Vegetable Seed Holding LLC, Monsanto Western Production Co LLC, Monsanto Zaad B.V., Monsanto Zambia Ltd, Monsanto d. o. o., Pallas Versicherung, Pandias Re AG, Pianosa B.V., Relay Limited, SC Bayer SRL, SCEA De Ruiter Zonen Selection, Sechste Bayer Real Estate VV GmbH & Co., Seminis Vegetable Seeds U. K. Ltd, Siebte Bayer VV GmbH, Steigerwald Arzneimittelwerk GmbH, TECTRION GmbH, TOO Bayer KAZ, The Climate Corporation International SA, TravelBoard GmbH, UAB Bayer, Vierte Bayer Real Estate VV GmbH & Co., WeatherMe OÜ, Zeptosens, Zoner.ag, Zweite Bayer Real Estate VV GmbH & Co., and Zweite K-W-A Beteiligungsgesellschaft mbH.
Read More
How can I contact Bayer Aktiengesellschaft?: Bayer Aktiengesellschaft's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The official website for the company is www.bayer.com. The company can be reached via phone at 49214301, via email at peter.dahlhoff@bayer.com, or via fax at 49-21-4306-6328.

This page (OTCMKTS:BAYRY) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bayer Aktiengesellschaft - BAYRY Stock Forecast, Price & News

Bayer Aktiengesellschaft MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Stock

BAYRY Stock News Headlines

BAYRY Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

BAYRY Stock - Frequently Asked Questions

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™